Andres Kohan

9PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisRegenerative medicine (incl. stem cells)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 27, 2024
18F-Fluoroazomycin Arabinoside (FAZA) PET/MR as a Biomarker of Hypoxia in Rectal Cancer: A Pilot Study.

Ur Metser, Andres Kohan, Catherine O'Brien

|Sep 11, 2024
CXCR4-Targeted PET Imaging in Hematologic Malignancies: A Systematic Review and Meta-analysis.

Mohammadreza Chavoshi, Seyed Ali Mirshahvalad, Andres Kohan

|Jun 19, 2024
Gastro-Esophageal Cancer: Can Radiomic Parameters from Baseline 18F-FDG-PET/CT Predict the Development of Distant Metastatic Disease?

Ricarda Hinzpeter, Seyed Ali Mirshahvalad, Roshini Kulanthaivelu

|May 25, 2024
The [18F]F-FDG PET/CT Radiomics Classifier of Histologic Subtypes and Anatomical Disease Origins across Various Malignancies: A Proof-of-Principle Study.

Ricarda Hinzpeter, Seyed Ali Mirshahvalad, Vanessa Murad

|Dec 14, 2023
Detection of metabolic adaptation in a triple-negative breast cancer animal model with [18F]choline-PET imaging as a surrogate for drug resistance.

Andres A Kohan, Mathieu Lupien, David Cescon

|Nov 25, 2023
Impact of the COVID-19 Pandemic on Staging Oncologic PET/CT Imaging and Patient Outcome in a Public Healthcare Context: Overview and Follow Up of the First Two Years of the Pandemic.

Andres Kohan, Sumesh Menon, Vanessa Murad

Pageof 2

Frequent Collaborators

6 joint publications

Ur Metser

4 joint publications

Roshini Kulanthaivelu

4 joint publications

Adam Farag

4 joint publications

Seyed Ali Mirshahvalad